Companies/US/PYXS

PYXIS ONCOLOGY, INC.

Last · NASDAQ$3.565-0.185 (-4.93%)stale · yahoo · 122h ago
Market cap$297.35M83.4M sh
P/E · TTM-2.5fwd -3.2 · eps -1.40 · loss
Beta1.32vs S&P 500
Div yield—annual · TTM
52w range
$1.03$5.55
Volume812.0Ksession

Issuer

Legal namePYXIS ONCOLOGY, INC.
HQUnited States (US)
ListingUS PYXS
ISINUS7473241013
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001782223
CIK0001782223
Websitewww.pyxisoncology.com
LinkedIn
Employees56
AddressPyxis Oncology, Inc. 321 Harrison Avenue 02118, Boston
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.28
Est. revenue
0
View financial calendar →

Press & signals

2 recent
  • GlobeNewswire

    Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

  • GlobeNewswire

    Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Documents

FormReporting forFiledFlags
4
2026-09-042026-09-080
8-K
2026-09-032026-09-080
8-K
2026-08-132026-08-130
10-Q
2026-06-302026-08-13 3
8-K
2026-06-302026-07-020
Showing 5 of 5 filings